Skip to content

Nuvation Bio NUVB Operating margin

Operating margin at other companies

Immunome logo
ImmunomeIMNM
-5,947.9%-12,002pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-168.6%-52.7pp
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
-127.2%-31.0pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-4,671.1%-5,434pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-185.4%-83.3pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-206.2%-61.0pp

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's operating margin?
Nuvation Bio (NUVB) reported operating margin of -105% in Q1 2026.
How has Nuvation Bio's operating margin changed year-over-year?
Nuvation Bio's operating margin increased by 98.2% year-over-year, from -5,762.8% to -105%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.